Compound 2341
Identifiers
- Common name: EML631
- Canonical SMILES:
O=C(N1CCC(CCN2CCCC2)CC1)c1ccc(C(=O)N2CCC(CCN3CCCC3)CC2)c(Nc2ccc(OCN3CCCC3)cc2)c1
- IUPAC name:
2,5-bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidine-1-carbonyl})-N-{4-[(pyrrolidin-1-yl)methoxy]phenyl}aniline - InChi:
InChI=1S/C41H60N6O3/c48-40(46-27-15-33(16-28-46)13-25-43-19-1-2-20-43)35-7-12-38(41(49)47-29-17-34(18-30-47)14-26-44-21-3-4-22-44)39(31-35)42-36-8-10-37(11-9-36)50-32-45-23-5-6-24-45/h7-12,31,33-34,42H,1-6,13-30,32H2
- InChiKey:
LPCWQWNRCGWRFC-UHFFFAOYSA-N
External links
![]() 126480597 |
![]() CHEMBL4476514 |
6PD |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 4 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| SPIN1 / H3 | 5.41 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 684.47 g/mol | |||
| HBA | 9 | |||
| HBD | 1 | |||
| HBA + HBD | 10 | |||
| AlogP | 6.21 | |||
| TPSA | 74.00 | |||
| RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| 10.1038/NCHEMBIO.2377 | EML631 | SPIN1 Q9Y657 |
Q5TEC6 Q5TEC6 |
Biochemical assay | Isothermal Titration Calorimetry | pKd (dissociation constant, -log10) | 5.41 | |
| 10.1038/NCHEMBIO.2377 | EML631 | SPIN1 Q9Y657 |
Q5TEC6 Q5TEC6 |
Biochemical assay | Isothermal Titration Calorimetry PHF20 | pKd (dissociation constant, -log10) | 3.77 | |
| 10.1038/NCHEMBIO.2377 | EML631 | SPIN1 Q9Y657 |
Q5TEC6 Q5TEC6 |
Biochemical assay | Isothermal Titration Calorimetry 53BP1 | pKd (dissociation constant, -log10) | 4.09 | |
| 10.1038/NCHEMBIO.2377 | EML631 | SPIN1 Q9Y657 |
Q5TEC6 Q5TEC6 |
Biochemical assay | Isothermal Titration Calorimetry L3MBTL3 | pKd (dissociation constant, -log10) | 3.98 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.5497 | Delparantag | DB12955 | |
| 0.4931 | Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester | DB03748 | |
| 0.4880 | Cobimetinib | DB05239 | |
| 0.4806 | Demecarium | DB00944 | |
| 0.4766 | 4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline | DB08579 | |
| 0.4709 | Repaglinide | DB00912 | |
| 0.4640 | 4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid | DB08581 | |
| 0.4615 | 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide | DB02565 | |
| 0.4540 | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | DB07801 | |
| 0.4533 | Renzapride | DB04917 | |
| 0.4506 | XL-888 | DB12981 | |
| 0.4488 | Aniracetam | DB04599 | |
| 0.4472 | TD-8954 | DB12725 | |
| 0.4444 | N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide | DB08582 | |
| 0.4430 | Pomalidomide | DB08910 |




